Comparing USCOM and Echocardiographic Hemodynamic Measurements in Children (CUE Study)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02083172 |
Recruitment Status :
Completed
First Posted : March 11, 2014
Last Update Posted : March 16, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Hemodynamically Stable Critical Illness | Device: Ultrasound Cardiac Output Monitor and 2 D-Echo |
Study Type : | Observational |
Actual Enrollment : | 78 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Evaluating Agreement Between USCOM and 2D-echocardiographic Hemodynamic Measurements in Pediatric Patients |
Study Start Date : | July 2014 |
Actual Primary Completion Date : | December 2015 |
Actual Study Completion Date : | January 2016 |
Group/Cohort | Intervention/treatment |
---|---|
Hemodynamically stable patients
Hemodynamically stable patients will be defined as patients with normal hemodynamic profile as evidenced by normal age-determined vital signs and normal perfusion.
|
Device: Ultrasound Cardiac Output Monitor and 2 D-Echo
Hemodynamic measurements obtained by 2D-Echo and USCOM will be compared.
Other Name: USCOM |
Hemodynamically unstable patients
Hemodynamically unstable patients will be defined as patients who are admitted to the Pediatric Critical Care Unit (PCCU), in whom there is a clinical diagnosis of shock as evidenced by signs and symptoms of hypoperfusion, requiring fluid resuscitation and/or inotropic support.
|
Device: Ultrasound Cardiac Output Monitor and 2 D-Echo
Hemodynamic measurements obtained by 2D-Echo and USCOM will be compared.
Other Name: USCOM |
Mechanically ventilated patients
Patients requiring mechanical ventilation
|
Device: Ultrasound Cardiac Output Monitor and 2 D-Echo
Hemodynamic measurements obtained by 2D-Echo and USCOM will be compared.
Other Name: USCOM |
- Agreement in hemodynamic measurements obtained by USCOM and 2D-Echo respectively, in hemodynamically stable children [ Time Frame: Within 30 minutes of first measurement method ]Hemodynamic measurements are include cardiac output (CO), Stroke Volume (SV),Aortic cross sectional area (Ao CSA), Preload (SVV%) Inferior Vena cava Collapsibility index (IVC), Inotropy (SMI) and (EF)
- Agreement in hemodynamic measurements obtained by USCOM and 2D-Echo, in hemodynamically unstable children, and children receiving positive pressure ventilation respectively [ Time Frame: Within 30 minutes of first measurement method ]Hemodynamic measurements are include Cardiac Output (CO), Stroke Volume(SV), Preload (SVV%) and IVC collapsibility Index, Inotropy

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 1 Month to 18 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
- The hemodynamically stable group: will be screened from pediatric in-patients on McMaster Children's Hospital general pediatric wards and those scheduled for elective 2D-echo through cardiology and sedation clinic.
- The hemodynamically unstable patients and 3. those requiring mechanical ventilation will be screened from McMaster Children's Hospital Pediatric Critical Care Unit.
Inclusion Criteria:
- Age under 18 years
- Patient fulfills clinical criteria for either study cohort
- Most Responsible Physician has ordered an ECHO study on the patient
- Written informed consent by parents/legal guardian/substitute decision maker, and assent where appropriate
- Patients with normal cardiac structure, no pre-existing primary cardiovascular disease or hemodynamically insignificant shunt lesions (i.e. hemodynamically insignificant Atrial Septal Defect/Patent Foramen Oval and Ventricular Septal Defect
Exclusion Criteria:
- Age ≥ 18 years
- Premature infants (born <37 weeks gestation) admitted to the Neonatal Intensive Care Unit
- Known co-existing primary cardiac anomalies (i.e. aortic or pulmonary valve stenosis or regurgitation, Aortic Valve regurgitation, shunt lesions save for those mentioned above, and pericardial effusion)
- Prior enrollment in study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02083172
Canada, Ontario | |
McMaster Children's Hospital | |
Hamilton, Ontario, Canada, L8S 4K1 |
Study Chair: | Karen Choong, MD,BCh,MSc | McMaster University |
Responsible Party: | Karen Choong, Associate professor, Departments of Pediatrics and Critical Care, McMaster University |
ClinicalTrials.gov Identifier: | NCT02083172 |
Other Study ID Numbers: |
13-658 |
First Posted: | March 11, 2014 Key Record Dates |
Last Update Posted: | March 16, 2016 |
Last Verified: | November 2015 |
USCOM (UltraSound Cardiac Output Monitor) 2D echocardiography agreement pediatrics |
Critical Illness Disease Attributes Pathologic Processes |